UiPath (NYSE:PATH) Stock Price Up 0.5%

UiPath Inc. (NYSE:PATH) shares rose 0.5% during mid-day trading on Wednesday . The company traded as high as $19.91 and last traded at $19.65. Approximately 1,215,390 shares traded hands during trading, a decline of 86% from the average daily volume of 8,732,511 shares. The stock had previously closed at $19.55.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on PATH shares. Wells Fargo & Company upped their target price on UiPath from $24.00 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, March 14th. Scotiabank increased their price objective on UiPath from $29.00 to $30.00 and gave the company a “sector perform” rating in a report on Thursday, March 14th. Needham & Company LLC restated a “buy” rating and issued a $30.00 target price on shares of UiPath in a research note on Wednesday, March 20th. William Blair began coverage on UiPath in a research report on Tuesday, January 2nd. They set an “outperform” rating on the stock. Finally, KeyCorp started coverage on UiPath in a research report on Monday, April 8th. They set an “overweight” rating and a $27.00 price target on the stock. Nine investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $27.41.

UiPath Price Performance

The stock has a fifty day moving average price of $22.55 and a two-hundred day moving average price of $21.56. The company has a market cap of $11.21 billion, a P/E ratio of -115.58 and a beta of 0.96.

UiPath (NYSE:PATH) last released its quarterly earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.10. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. The company had revenue of $405.25 million for the quarter, compared to analysts’ expectations of $383.32 million. As a group, analysts forecast that UiPath Inc. will post -0.04 earnings per share for the current year.

Insider Buying and Selling

In other UiPath news, CFO Ashim Gupta sold 16,000 shares of UiPath stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $22.47, for a total value of $359,520.00. Following the transaction, the chief financial officer now owns 103,505 shares in the company, valued at $2,325,757.35. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders have sold a total of 72,000 shares of company stock valued at $1,591,360 over the last quarter. Corporate insiders own 31.03% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Intech Investment Management LLC grew its position in UiPath by 3.1% during the 4th quarter. Intech Investment Management LLC now owns 14,324 shares of the healthcare company’s stock worth $356,000 after purchasing an additional 426 shares in the last quarter. 180 Wealth Advisors LLC grew its position in UiPath by 0.3% during the 4th quarter. 180 Wealth Advisors LLC now owns 188,950 shares of the healthcare company’s stock worth $4,497,000 after purchasing an additional 492 shares in the last quarter. Bleakley Financial Group LLC grew its position in UiPath by 4.9% during the 4th quarter. Bleakley Financial Group LLC now owns 12,691 shares of the healthcare company’s stock worth $315,000 after purchasing an additional 598 shares in the last quarter. Simplicity Solutions LLC grew its position in UiPath by 4.9% during the 4th quarter. Simplicity Solutions LLC now owns 12,691 shares of the healthcare company’s stock worth $315,000 after purchasing an additional 598 shares in the last quarter. Finally, GAMMA Investing LLC grew its position in UiPath by 40.2% during the 1st quarter. GAMMA Investing LLC now owns 2,204 shares of the healthcare company’s stock worth $50,000 after purchasing an additional 632 shares in the last quarter. Institutional investors and hedge funds own 62.50% of the company’s stock.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.